We are in constant search of partners who match our values, work ethics and commitment to patients. We regard partnership and collaboration as an integral part of our business strategy. This important initiative is supported by a dedicated team for global business development, licensing and post-alliance management. We offer a full range of both global and local integrated, organisational and commercial capabilities, combined with a history of successful product launch.We constantly seek to strengthen our presence, with a range of generic and specialty generic (505(b)2) products, in global markets.All our efforts are towards continuing growth and to achieve this we are looking to in-license technology based specialty generics such as, but not limited to, long acting injectable, liposomes, implants, drug-device combination products, oral films, etc. We constantly seek to establish and strengthen long term, mutually rewarding business relationship based on suitable business models like co-development, licensing or fees for service. We believe in investing in our partners and extending all technical expertise wherever is required.
